Literature DB >> 20884176

Roles of atrial natriuretic peptide and its therapeutic use.

Yoshihiko Saito1.   

Abstract

Since the discovery of atrial natriuretic peptide (ANP), there has been tremendous progress in our understanding of the physiologic and pathophysiologic, diagnostic, and therapeutic roles of ANP. The diagnostic application of ANP and brain natriuretic peptide (BNP) has been reviewed by many investigators, and meta-analyses of therapeutic use of BNP were reported from the USA. However, there are few reviews concerning the therapeutic use of ANP in patients with various conditions. Therefore, this review focuses on the recent clinical evidence of ANP in therapeutic use and experimental data that rationally support the therapeutic use of ANP.
Copyright © 2010 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20884176     DOI： 10.1016/j.jjcc.2010.08.001

Source DB:  PubMed          Journal:  J Cardiol        ISSN： 0914-5087            Impact factor:   3.159


  36 in total

1.  Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device.

Authors:  Ryan Maybrook; Jayasree Pillarisetti; Vivek Yarlagadda; Sampath Gunda; Arun Raghav Mahankali Sridhar; Brent Deibert; Muhammad R Afzal; Madhu Reddy; Donita Atkins; Matthew Earnest; Ryan Ferrell; Jayant Nath; Arun Kanmanthareddy; Sudharani Bommana; Rajasingh Johnson; Sandeep Reddy Koripalli; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2015-05-09       Impact factor: 1.900

2.  Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides.

Authors:  Fumiki Yoshihara; Takeshi Tokudome; Ichiro Kishimoto; Kentaro Otani; Atsunori Kuwabara; Takeshi Horio; Yuhei Kawano; Kenji Kangawa
Journal:  Clin Exp Nephrol       Date:  2014-05-21       Impact factor: 2.801

3.  Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy.

Authors:  Pang-Hu Zhou; Lei Shi; Wei Hu; Xiao-Bin Zhang; Wei Wang; Li-Jun Zhang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

4.  Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade.

Authors:  Shuichi Fujita; Naoshi Shimojo; Fumio Terasaki; Kaoru Otsuka; Noriko Hosotani; Yuka Kohda; Takao Tanaka; Tomohiro Nishioka; Toshimichi Yoshida; Michiaki Hiroe; Yasushi Kitaura; Nobukazu Ishizaka; Kyoko Imanaka-Yoshida
Journal:  Heart Vessels       Date:  2013-01-01       Impact factor: 2.037

5.  Plasma concentrations of adrenomedullin and atrial and brain natriuretic peptides in patients with adrenal pheochromocytoma.

Authors:  Wei Hu; Lei Shi; Pang-Hu Zhou; Xiao-Bin Zhang
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

Review 6.  Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).

Authors:  Wei Song; Hao Wang; Qingyu Wu
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

Review 7.  Novel drug targets in clinical development for heart failure.

Authors:  Melvin George; Muthukumar Rajaram; Elangovan Shanmugam; Thangavel Mahalingam VijayaKumar
Journal:  Eur J Clin Pharmacol       Date:  2014-04-09       Impact factor: 2.953

8.  Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.

Authors:  Ming-Yi Lv; Shu-Ling Deng; Xiao-Feng Long
Journal:  Br J Clin Pharmacol       Date:  2015-11-28       Impact factor: 4.335

Review 9.  Nocturia: aetiology and treatment in adults.

Authors:  Hasan Dani; Ashanda Esdaille; Jeffrey P Weiss
Journal:  Nat Rev Urol       Date:  2016-07-26       Impact factor: 14.432

10.  New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions.

Authors:  Thomas Mondritzki; Philip Boehme; Lena Schramm; Julia Vogel; Ilka Mathar; Peter Ellinghaus; Peter Kolkhof; Erwin Bischoff; Jörg Hüser; Wilfried Dinh; Peter Sandner; Hubert Truebel
Journal:  Eur J Appl Physiol       Date:  2017-11-20       Impact factor: 3.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.